ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2,2,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2,7,Proteus infection,Proteus infections,Bacterial infectious disorders,Infec,N
2,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,10,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2,11,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2,13,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
5,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,2,Iliolumbar syndrome,Ligament disorders,"Tendon, ligament and cartilage disorders",Musc,N
5,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5,4,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
6,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
8,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
8,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9,1,Granulomatous lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
9,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
9,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
9,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
9,5,Primary mediastinal large B-cell lymphoma,Primary mediastinal large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
9,6,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
9,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
12,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,Y
13,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
14,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
15,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
15,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
16,1,Diffuse large B-cell lymphoma stage IV,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
16,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
17,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
17,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
17,3,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
17,4,Headache,Headaches NEC,Headaches,Nerv,N
17,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
17,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
17,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,8,Postural orthostatic tachycardia syndrome,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
17,9,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
17,10,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
20,1,Tumour flare,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
21,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
22,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
23,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
24,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
24,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
25,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
26,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
28,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
29,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
30,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
30,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
30,3,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
30,4,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
30,5,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
30,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
30,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
30,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
31,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
31,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
31,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
31,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
31,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
32,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
32,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
33,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
35,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
36,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
36,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
37,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
38,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
38,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
39,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
39,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
40,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
40,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
40,3,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
41,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
42,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
42,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
42,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
42,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
43,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
43,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
44,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
46,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
46,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
47,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
47,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
48,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
50,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
50,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
50,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
50,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
51,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
52,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
52,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
52,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
53,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
53,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
53,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
53,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
53,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
53,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
54,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
54,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
54,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
55,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
55,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
55,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
55,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
56,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
57,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
58,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
58,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
60,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
62,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
62,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
63,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
64,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
65,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
65,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
68,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
70,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
70,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
70,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
71,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
72,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
72,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
72,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
73,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
74,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
74,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
76,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
76,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
77,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
79,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
81,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
82,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
82,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
82,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
83,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
84,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
85,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
87,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
88,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
89,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
89,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
89,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
89,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
89,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
89,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
90,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
91,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
91,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
92,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
94,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
94,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
95,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
96,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
96,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
96,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
96,4,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
96,5,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
96,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
96,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
96,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
97,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
98,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
100,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
100,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
101,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
103,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
104,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
105,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
106,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
108,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
108,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
109,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
109,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
109,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
109,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
109,5,JC polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
109,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
109,7,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
109,8,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
110,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
111,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
111,2,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
112,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
115,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
115,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
116,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
117,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
117,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,3,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
117,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
118,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
118,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
118,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
119,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
119,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
119,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
120,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
121,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
122,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
122,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
123,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
123,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
123,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
123,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
123,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
123,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
123,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
123,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
123,9,Inflammation,Inflammations,General system disorders NEC,Genrl,N
123,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,11,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
123,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
123,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
124,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
125,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
